Jazz Pharmaceuticals has an unwavering commitment to improving care for patients with serious medical conditions through innovative treatments. Our development pipeline projects currently include clinical development of new product candidates, line extensions for existing products and the generation of additional clinical data for existing products.


*Current as of 2/13/15
1 Evaluating in children and adolescents who have narcolepsy with cataplexy.
EDS = Excessive Daytime Sleepiness, OSA = Obstructive Sleep Apnea, VOD = Hepatic Veno-Occlusive Disease, NDA = New Drug Application, IV = intravenous, sBLA = supplemental Biologics License
Application, ALL = Acute Lymphoblastic Leukemia, YA = Young Adults, PK = Pharmacokinetic, aGvHD = Acute Graft vs. Host Disease